The global pediatric medical devices market, valued at US$ 27.6 Bn in 2022, is projected to grow at a compound annual growth rate (CAGR) of 6.3% from 2023 to 2031, reaching an estimated US$ 47.4 Bn by the end of the forecast period. Increasing prevalence of pediatric diseases, a surge in premature births, and advancements in medical technology are key factors driving market growth, while targeted R&D and strategic investments are expanding product portfolios across various segments.
The pediatric medical devices market is experiencing robust growth as healthcare providers worldwide respond to rising rates of pediatric diseases—including obesity, diabetes, and asthma—and increased incidences of premature births. Heightened awareness about pediatric health, combined with significant investments in research and development, is fostering innovation in devices tailored to the unique physiology and developmental needs of children. Key players are increasingly integrating artificial intelligence into devices for improved disease monitoring and early intervention, particularly in the management of pediatric asthma.
Market Introduction
Pediatric medical devices are specialized instruments and technologies designed to diagnose, treat, and monitor conditions in patients under the age of 21. These devices encompass a broad range of applications including in vitro diagnostic (IVD) devices, cardiology devices, diagnostic imaging systems, anesthesia & respiratory care devices, neonatal ICU devices, monitoring tools, telemedicine platforms, and home-use medical devices. They are engineered with consideration for smaller body sizes, unique developmental stages, and pediatric physiology, ensuring safety and efficacy in newborns, children, and adolescents.
Key Market Drivers
- Rising Prevalence of Pediatric Diseases:
An increase in chronic conditions such as asthma, diabetes, and obesity is driving the need for advanced diagnostic and treatment devices. For instance, the CDC estimates that approximately 6.2 million children in the U.S. suffer from asthma, spurring demand for innovative management and monitoring solutions. - Increase in Cases of Premature Birth:
With one in every 10 babies born prematurely worldwide, the need for neonatal ICU devices and monitoring systems has escalated. These devices are critical for monitoring vital parameters and providing supportive care to vulnerable newborns. - Technological Advancements and R&D Investments:
Major industry players are investing in next-generation devices that integrate artificial intelligence for enhanced disease tracking and remote patient monitoring. Such innovations are improving pediatric outcomes and expanding the application of pediatric medical devices across various clinical settings. - Expanding Healthcare Infrastructure:
Growth in healthcare infrastructure and increased investment in pediatric care, particularly in North America and Asia Pacific, are creating favorable market conditions for the adoption of advanced pediatric medical devices.
Regional Insights
North America held the largest market share in 2022, driven by high R&D investments, advanced healthcare facilities, and robust government initiatives aimed at improving pediatric care. In addition, increased awareness of pediatric diseases and premature birth complications has further fueled market growth in the region. Europe and Asia Pacific are also witnessing significant expansion due to rising healthcare investments and the adoption of state-of-the-art diagnostic and treatment technologies.
Analysis of Key Players
The pediatric medical devices market is highly competitive, with key players expanding their portfolios through mergers and acquisitions, strategic partnerships, and new product launches. Prominent companies include:
- Abbott
- Boston Scientific Corporation
- Baxter International, Inc.
- Medtronic
- Cardinal Health, Inc.
- F. Hoffmann-La Roche Ltd.
- GE Healthcare
- Johnson & Johnson
- Siemens Healthineers
- Koninklijke Philips N.V.
- Stryker Corporation
These companies are leveraging advanced technologies such as AI-powered monitoring and remote patient management to improve clinical outcomes and expand their presence in the pediatric market.
Key Developments
- February 2024: Aevice Health, a Singapore-based developer of pediatric respiratory support devices, partnered with U.K.-based Jiva.ai to develop a remote patient monitoring platform designed to track pediatric asthma and predict potential attacks.
- January 2022: Good Parents Inc. announced the closure of a US$ 16 Mn series growth investment led by Clearlake Capital-backed Vive Collective to further expand its Kiddo remote patient monitoring and continuous care platform for pediatric patients.
Market Segmentation
The global medical devices market is segmented based on product type, end-user, and geography. By product, the market includes In Vitro Diagnostic (IVD) Devices, Cardiology Devices, Diagnostic Imaging Devices, Anesthesia & Respiratory Care Devices, Neonatal ICU Devices, Monitoring Devices, Telemedicine, and Home-use Medical Devices. In terms of end-users, the market is categorized into hospitals, diagnostic laboratories, ambulatory surgical centers (ASCs), and others. Geographically, the market spans North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa, with key countries covered including the U.S., Canada, Germany, U.K., France, Spain, Italy, Russia & CIS, Japan, China, India, ASEAN, Brazil, Mexico, GCC, and South Africa.
Frequently Asked Questions (FAQ)
Q1: What are pediatric medical devices?
A: Pediatric medical devices are specialized instruments and technologies designed to diagnose, treat, and monitor health conditions in children from infancy through adolescence. They are tailored to the unique anatomical and physiological needs of pediatric patients.
Q2: What factors are driving the pediatric medical devices market?
A: Key drivers include the rising prevalence of pediatric diseases such as asthma, obesity, and diabetes; an increase in premature births; and significant investments in research and development. These factors, combined with advancements in technology, are fueling market growth.
Q3: Which product segments are included in the pediatric medical devices market?
A: The market includes a wide range of products such as in vitro diagnostic devices, cardiology devices, diagnostic imaging systems, anesthesia & respiratory care devices, neonatal ICU devices, monitoring devices, telemedicine platforms, and home-use medical devices.
Q4: Which regions are leading the market?
A: North America leads the market due to its advanced healthcare infrastructure and high R&D investments. Europe and Asia Pacific are also experiencing strong growth driven by increasing pediatric healthcare needs and the adoption of advanced technologies.
Q5: Who are the key players in the pediatric medical devices market?
A: Prominent companies include Abbott, Boston Scientific Corporation, Baxter International, Inc., Medtronic, Cardinal Health, F. Hoffmann-La Roche Ltd., GE Healthcare, Johnson & Johnson, Siemens Healthineers, Koninklijke Philips N.V., and Stryker Corporation.
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
